Many studies have reported on the mechanism and treatment of NSCLC with the help of immunotherapy, which has increasingly become a hot spot in the field, especially represented by PD-1/PD-L1 inhibition (Fig. S1A). This evidence concerns the gene CD274 and non-small cell lung carcinoma.